Connect with us

COVID-19

Oxygen producing plant inaugurated at Kabul Hospital

Published

 on

(Last Updated On: November 30, 2020)

An oxygen-producing plant was inaugurated on Sunday at Muhammad Ali Jinnah Hospital in the capital Kabul city.

A number of high-ranking government officials including Ahmad Jawad Osmani, Acting Minister of Public Health, and several MPs and Monsoor Ahmad Khan Ambassador of Pakistan to Kabul had attended the inauguration ceremony of the plant.  

The plant with a capacity of producing 50 balloons of oxygen per hour would meet patients’ needs at the hospital. 

The 300-bed Jinnah Hospital, which was one of the capital’s Covid-19 isolation centers, is constructed by the government of Pakistan in Dasht-e-Barchi of the city at a cost of $24 million.

Addressing the inauguration ceremony, Monsoor Ahmad Khan stated that Pakistan is committed to assisting Afghanistan in development projects.

“We are trying to establish a cancer treatment center at the Ali Jinnah Hospital. Pakistan is ready to assist Afghanistan in various areas, even peace,” the Pakistani Ambassador said. 

At the inauguration ceremony, Public Health Acting Minister Jawad Osmani warned of the second wave of Covid-19 in the country.

He stated that around 1240 people have been infected with Covid-19 in the past week. According to him, the infections have increased by 10 percent and the fatalities have increased by 3 percent.

COVID-19

Global COVID-19 cases exceed 236 million, death toll hits 4.83 million

Published

on

(Last Updated On: October 11, 2021)

The cumulative total number of global COVID-19 cases has exceeded 236.5 million with the death toll hitting 4.83 million as of Friday, according to the latest data compiled by the World Health Organization (WHO).

Specifically, there had been 236,599,025 confirmed cases of COVID-19, including 4,831,486 deaths as of Wednesday, the WHO’s COVID-19 dashboard showed Monday.

In addition, a total of 6.3 billion vaccine doses had been administered across the world as of Saturday, according to the WHO.

The cumulative total of confirmed COVID-19 cases in the United States topped 44.3 million as of Sunday, with the death toll surpassing 713,000, according to the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.

The country’s case count rose to 44,338,297 on Sunday, and its death toll came to 713,154, the CSSE tally showed.

As of early Monday morning, a total of 400,352,880 doses of COVID-19 vaccines had been administered across the United States, CSSE data showed.

Reuters reported that in Britain, another 34,574 people have tested positive for COVID-19, bringing its total coronavirus cases to 8,154,306, according to official figures released Sunday.

The country also recorded another 38 coronavirus-related deaths. The total number of coronavirus-related deaths in Britain now stands at 137,735. These figures only include the deaths of people who died within 28 days of their first positive test.

There are currently 6,763 patients in hospital in the UK with COVID-19.

Russia meanwhile confirmed 28,647 new COVID-19 cases over the past 24 hours, taking the national tally to 7,775,365, the official monitoring and response center said Sunday.

The nationwide death toll grew by 962, close to a record number of 968 a day earlier, to 216,415. Recoveries increased by 17,274 to 6,858,119.

In Asia, India’s COVID-19 tally rose to 33,971,607 on Monday, as 18,132 new cases were registered during the past 24 hours across the country, showed the federal health ministry’s latest data.

The number of new cases recorded in a day are the lowest in the past 215 days, said a statement by the federal health ministry.

Besides, as many as 193 deaths from the pandemic since Sunday morning took the total death toll to 450,782.

Continue Reading

COVID-19

U.S. COVID-19 cases surpass 44.2 million, death toll tops 710,000

Published

on

(Last Updated On: October 9, 2021)

The cumulative total of confirmed COVID-19 cases in the United States topped 44.2 million as of Friday, with the death toll surpassing 712,000, according to the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.

The country’s case count rose to 44,285,030 on Friday, and its death toll came to 712,646, the CSSE tally showed.

The Alaska state in northwestern America has recently witnessed a sharp surge in COVID-19 patients and a shortage of medical resources.

The state has become one of the country’s hardest-hit places by the pandemic, as reported by some local media on Friday.

In the past two weeks, the number of deaths from COVID-19 in the United States has increased by more than three times, and most of the new cases did not get vaccinated.

In addition, the rural area in Alaska is more vulnerable to the pandemic.

The Centers for Disease Control and Prevention said on Thursday that COVID-19 associated multisystem inflammatory syndrome cases in children has increased by 12 percent since late August, the largest growth so far this year.

Continue Reading

COVID-19

Children take part in vaccine study as Pfizer seeks FDA approval

Published

on

(Last Updated On: October 8, 2021)

Pfizer Inc and BioNTech have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Thursday (October 07), Reuters reported.

A trial to test vaccine safety on children took place at Duke University School of Medicine. Two of the children who took part, were 7 year old Lydia and her sister, 5 year old Bridgette.

Both of the girls were calm as they received their vaccinations, although Bridgette instructed her father to hold her hand, read the report.

The U.S. Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss Pfiizer’s application, making it possible for children in this age group – numbering around 28 million – to begin receiving the two-dose Pfizer/BioNTech vaccine shortly afterward.

The vaccine already has won U.S. emergency use authorization in teens ages 12 to 15 and is fully approved by regulators for people ages 16 and up.

The Pfizer/BioNTech vaccine is one of three in use in the United States, along with the two-dose Moderna vaccine and the single-dose Johnson & Johnson version, neither of which has won full regulatory approval for any age group.

A rapid authorization of the Pfizer/BioNTech vaccine in young kids could help mitigate a potential surge of cases in the coming weeks and months, with schools open nationwide and colder weather driving activities indoors. If given regulatory authorization, the two-dose Pfizer/BioNTech vaccine would become the first COVID-19 shot made available to children 5 to 11 in the United States, Reuters reported.

Continue Reading

Trending

Copyright © 2021 Ariana News. All rights reserved!